28 participants
Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-09
- Start Date:
- 2026-07-20
- Completion:
- 2027-09-30
Conditions
- Gastric Cancer
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Becotatug Vedotin
- Pucotenlimab
Interventions
- DRUG
No Results Yet